Treatment of Androgenetic Alopecia in Females, 12 Beam
Completed · Not applicable · Has a placebo group
Conditions studied: Androgenetic Alopecia, Hair Loss, Female Pattern Baldness
In brief
The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 12 beam model for androgenetic alopecia in females when treatment is applied as directed.
Key facts
- Study ID
- NCT01016964
- Run by
- Lexington International, LLC
- People needed
- 63
- Starts
- 2010-01-01
- Expected to finish
- 2011-03-01
- Last updated by the study team
- 2012-09-07
Who can join
Age: 25 and older, up to 60. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Diagnosis of androgenetic alopecia
- Fitzpatrick Skin types I-IV
- Ludwig I-4, II-1, II-2, or frontal
- Active hair loss within last 12 months
You may not qualify if…
- Photosensitivity to laser light
- Malignancy in the target area
- Pregnancy
- Lactating females
Where it is running
- University of Miami Miller School of Medicine - Dermatology — Miami, Florida, United States
- University of Minnesota, Department of Dermatology — Minneapolis, Minnesota, United States
- Cleveland Clinic Foundation - Department of Dermatology — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.